Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach.
Saved in:
| Title: | Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach. |
|---|---|
| Authors: | Strathe A; Novo Nordisk A/S, Søborg, Denmark., Bomberg EM; Center for Pediatric Obesity Medicine and Division of Endocrinology, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA., Jensch G; Novo Nordisk A/S, Søborg, Denmark., Kildegaard J; Novo Nordisk A/S, Søborg, Denmark., Harder-Lauridsen NM; Novo Nordisk A/S, Søborg, Denmark., Weghuber D; Paracelsus Medical University, Department of Pediatrics, Salzburg, Austria., Overgaard RV; Novo Nordisk A/S, Søborg, Denmark. |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Jun; Vol. 28 (6), pp. 4926-4934. Date of Electronic Publication: 2026 Mar 30. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1463-1326 |
|---|---|
| DOI: | 10.1111/dom.70678 |
